Showing 2974 results
-
Press release /Anthos Therapeutics is a clinical-stage biopharmaceutical company developing abelacimab, a potential first-in-class monoclonal antibody targeting the FXI inhibition pathwayAbelacimab is currently in…
-
Media Library / -
Media Library / -
Media Library / -
Media Library / -
Media Library / -
Media Library / -
Media Library /